TRIVESPI Trademark

Trademark Overview

On Wednesday, February 21, 2018, a trademark application was filed for TRIVESPI with the United States Patent and Trademark Office. The USPTO has given the TRIVESPI trademark a serial number of 87805410. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, August 27, 2020. This trademark is owned by AstraZeneca AB. The TRIVESPI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in the treatment of respiratory diseases and disorders
trivespi

General Information

Serial Number87805410
Word MarkTRIVESPI
Filing DateWednesday, February 21, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, August 27, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in the treatment of respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Thursday, August 27, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, August 27, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, February 4, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, February 4, 2020INQUIRY TO SUSPENSION E-MAILED
Tuesday, February 4, 2020SUSPENSION INQUIRY WRITTEN
Thursday, January 23, 2020LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 8, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 8, 2019LETTER OF SUSPENSION E-MAILED
Monday, July 8, 2019SUSPENSION LETTER WRITTEN
Monday, July 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 1, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 23, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, January 23, 2019INQUIRY TO SUSPENSION E-MAILED
Wednesday, January 23, 2019SUSPENSION INQUIRY WRITTEN
Thursday, January 10, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, January 10, 2019ASSIGNED TO LIE
Thursday, May 17, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 17, 2018LETTER OF SUSPENSION E-MAILED
Thursday, May 17, 2018SUSPENSION LETTER WRITTEN
Monday, May 14, 2018ASSIGNED TO EXAMINER
Tuesday, February 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 24, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

trivespi diseases disorders respiratory treatment preparations substances pharmaceutical